Lilly's retatrutide shows remarkable weight loss in trials but raises concerns with side effects possibly linked to the drug like nausea and kidney stones. Read more here.
A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...
1hon MSN
Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...
"The launch of PeachesRx is the natural next step in Mangoceuticals' expansion as we continue to redefine direct-to-consumer ...
At the end of the day, weight loss options, like any other health-related decisions, are very personal and must be made on a ...
American doctors, who tracked over 37 million people, said the injections put users at higher risk of nonarteritic ischemic ...
Many patients with overweight or obesity discontinue GLP-1 receptor agonist therapy within 1 year, with higher discontinuation rates seen for those without type 2 diabetes.
A retrospective study demonstrated that GLP-1 receptor agonist use before pregnancy corresponded with lower risks for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback